Public Pathology Australia (and its predecessor, the National Coalition of Public Pathology) makes submissions to inquiries and reviews of governments and other bodies that affect public pathology as part of our advocacy activities.
Public Pathology Australia submissions include:
- Australian Competition and Consumer Commission (ACCC) on the competition effects of proposed company mergers and acquisitions in the Australian pathology services market.
Submission on Sonic’s acquisition of Adelaide Pathology Partners, Nov 2015.
- National Pathology Accreditation Advisory Council (NPAAC) on laboratory standards and requirements.
Submission on the NPAAC Communications Submission Aug 2015.
Submission on the NPAAC Requirements For The Clinical Governance And Supervision Of Medical Pathology Laboratories Submission Nov 2016.
Submission on the NPAAC Requirements for Laboratories Reporting Cervical Screening Submission Nov 2016.
- State Governments on reviews of pathology services
Submission on SA Pathology Review, Feb 2015.
- Federal Department of Health on funding under the Medicare Benefits Schedule (MBS), on applications to the Medical Services Advisory Committee (MSAC) for listing on the MBS, on strengthening the provisions of the Health Insurance Act 1973 and its secondary legislation.
Submission on MBS Review, Nov 2015.
Submission on the Impact of Cervical Screening Changes, Apr 2015
Submission on Managing MBS Outlays, Jan 2015.
- Senate Committees– such as the Community Affairs Committee on Gene Patents, a National Registration and Pathology Request Form Changes to give consumers greater choice of pathology provider and to the Legislative and Constitutional Committee on the Patent Amendment (Human Genes and Biological Materials) Bill 2010. Submission to the Senate Community Affairs Legislation Committee in relation to the National Cancer Screening Register Bill 2016 and National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016 Submission Sep 2016.